These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The possible neuroprotective effect of laudanosine, an atracurium and cisatracurium metabolite. Fodale V; Santamaria LB Acta Anaesthesiol Scand; 2003 Jul; 47(6):780; 780-1. PubMed ID: 12803601 [No Abstract] [Full Text] [Related]
3. Laudanosine and atracurium concentrations in a patient receiving long-term atracurium infusion. Grigore AM; Brusco L; Kuroda M; Koorn R Crit Care Med; 1998 Jan; 26(1):180-3. PubMed ID: 9428564 [TBL] [Abstract][Full Text] [Related]
4. Blockade and activation of the human neuronal nicotinic acetylcholine receptors by atracurium and laudanosine. Chiodini F; Charpantier E; Muller D; Tassonyi E; Fuchs-Buder T; Bertrand D Anesthesiology; 2001 Apr; 94(4):643-51. PubMed ID: 11379686 [TBL] [Abstract][Full Text] [Related]
5. Laudanosine (a metabolite of atracurium) increases the minimum alveolar concentration of halothane in rabbits. Shi WZ; Fahey MR; Fisher DM; Miller RD; Canfell C; Eger EI Anesthesiology; 1985 Dec; 63(6):584-8. PubMed ID: 2932981 [TBL] [Abstract][Full Text] [Related]
6. Plasma laudanosine levels in patients given atracurium during liver transplantation. Lawhead RG; Matsumi M; Peters KR; Landers DF; Becker GL; Earl RA Anesth Analg; 1993 Mar; 76(3):569-73. PubMed ID: 8452269 [TBL] [Abstract][Full Text] [Related]
7. [The clinical pharmacology of new benzylisoquinoline-diester compounds, with special consideration of cisatracurium and mivacurium]. Savarese JJ; Lien CA; Belmont MR; Wastila WB Anaesthesist; 1997 Oct; 46(10):840-9. PubMed ID: 9424966 [TBL] [Abstract][Full Text] [Related]
8. Atracurium decay and the formation of laudanosine in humans. Nigrovic V; Fox JL Anesthesiology; 1991 Mar; 74(3):446-54. PubMed ID: 2001023 [TBL] [Abstract][Full Text] [Related]
10. Neuromuscular interaction between cisatracurium and mivacurium, atracurium, vecuronium or rocuronium administered in combination. Kim KS; Chun YS; Chon SU; Suh JK Anaesthesia; 1998 Sep; 53(9):872-8. PubMed ID: 9849281 [TBL] [Abstract][Full Text] [Related]
11. Atracurium infusions in patients with fulminant hepatic failure awaiting liver transplantation. Bion JF; Bowden MI; Chow B; Honisberger L; Weatherley BC Intensive Care Med; 1993; 19 Suppl 2():S94-8. PubMed ID: 8106686 [TBL] [Abstract][Full Text] [Related]
12. [Metabolism and pharmacokinetics of atracurium]. Colin JN; Singlas E Ann Fr Anesth Reanim; 1985; 4(6):465-70. PubMed ID: 2936284 [TBL] [Abstract][Full Text] [Related]
13. Use of cisatracurium in critical care: a review of the literature. Szakmany T; Woodhouse T Minerva Anestesiol; 2015 Apr; 81(4):450-60. PubMed ID: 24721895 [TBL] [Abstract][Full Text] [Related]
14. The pharmacodynamics of mivacurium preceded by atracurium or cisatracurium in children. Jalkanen L; Rautoma P; Taivainen T; Meretoja OA Anesth Analg; 1998 Jan; 86(1):62-5. PubMed ID: 9428852 [TBL] [Abstract][Full Text] [Related]
15. Effects of neuromuscular blocking agents on excitatory transmission and gamma-aminobutyric acidA-mediated inhibition in the rat hippocampal slice. Chiodini FC; Tassonyi E; Fuchs-Buder T; Fathi M; Bertrand D; Muller D Anesthesiology; 1998 Apr; 88(4):1003-13. PubMed ID: 9579510 [TBL] [Abstract][Full Text] [Related]
16. Effect of renal failure on laudanosine excretion in man. Fahey MR; Rupp SM; Canfell C; Fisher DM; Miller RD; Sharma M; Castagnoli K; Hennis PJ Br J Anaesth; 1985 Nov; 57(11):1049-51. PubMed ID: 3840380 [TBL] [Abstract][Full Text] [Related]